industrial-scale production of antiparticles or antimatter is not currently feasible or economically viable. While small amounts of antiparticles have been produced in laboratory settings, generating them at a scale necessary for industrial applications is a significant technical and financial challenge.
The production of antiparticles requires high-energy particle accelerators, which are complex and expensive to build and operate. These accelerators collide particles at extremely high speeds to create antiparticles through processes such as pair production or particle-antiparticle annihilation.
At present, the cost of producing even tiny amounts of antimatter is extraordinarily high. Estimates vary, but it has been reported that the cost of producing just one microgram (0.000001 grams) of positrons (the antiparticle of the electron) using existing methods could range from hundreds of millions to billions of US dollars.
It's worth noting that antimatter has valuable applications in areas such as medical diagnostics (e.g., positron emission tomography or PET scans) and fundamental research. However, these applications typically involve small quantities of antimatter produced in specialized facilities, rather than large-scale industrial production.
While there may be ongoing research and developments in antimatter production, I do not have information on specific projects or plans for industrial-scale productionin 2021. It is recommended to consult up-to-date scientific literature or news sources for the latest information on this topic.